540,89 €
600,99 €
-10% with code: EXTRA
Profiles of Drug Substances, Excipients, and Related Methodology
Profiles of Drug Substances, Excipients, and Related Methodology
540,89
600,99 €
  • We will send in 10–14 business days.
Profiles of Drug Substances, Excipients, and Related Methodology, Volume 45, presents comprehensive reviews of drug substances and additional materials, with critical review chapters that summarize information related to the characterization of drug substances and excipients. The series encompasses review articles, with this release focusing on Azilsartan Medoxomil, Piroxicam, Carbetapentane Citrate, Emtricitabine, Etrlotinib, Isotretinoin and Meloxicam.
600.99
  • Publisher:
  • ISBN-10: 0128203234
  • ISBN-13: 9780128203231
  • Format: 15.2 x 22.9 x 2.7 cm, kieti viršeliai
  • Language: English
  • SAVE -10% with code: EXTRA

Profiles of Drug Substances, Excipients, and Related Methodology (e-book) (used book) | bookbook.eu

Reviews

Description

Profiles of Drug Substances, Excipients, and Related Methodology, Volume 45, presents comprehensive reviews of drug substances and additional materials, with critical review chapters that summarize information related to the characterization of drug substances and excipients. The series encompasses review articles, with this release focusing on Azilsartan Medoxomil, Piroxicam, Carbetapentane Citrate, Emtricitabine, Etrlotinib, Isotretinoin and Meloxicam.

EXTRA 10 % discount with code: EXTRA

540,89
600,99 €
We will send in 10–14 business days.

The promotion ends in 23d.15:16:00

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 6,01 Book Euros!?
  • Publisher:
  • ISBN-10: 0128203234
  • ISBN-13: 9780128203231
  • Format: 15.2 x 22.9 x 2.7 cm, kieti viršeliai
  • Language: English English

Profiles of Drug Substances, Excipients, and Related Methodology, Volume 45, presents comprehensive reviews of drug substances and additional materials, with critical review chapters that summarize information related to the characterization of drug substances and excipients. The series encompasses review articles, with this release focusing on Azilsartan Medoxomil, Piroxicam, Carbetapentane Citrate, Emtricitabine, Etrlotinib, Isotretinoin and Meloxicam.

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)